Discontinuation Of Tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis Patients In Low Disease Activity: Persistent Benefits.

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Lee, Susan J. [1 ]
Solomon, Daniel H. [2 ]
Greenberg, Jeffrey D. [3 ]
Kremer, Joel M. [4 ]
Soto, Lilian [5 ]
Etzel, Carol J. [6 ]
Reed, George W. [7 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol,Div Pharmacoepidemiol, Boston, MA 02115 USA
[3] NYU, Hosp Joint Dis, New York, NY USA
[4] Albany Med Coll, Ctr Rheumatol, Albany, NY 12208 USA
[5] Univ Calif San Diego, San Diego, CA 92103 USA
[6] CORRONA Inc, Houston, TX USA
[7] CORRONA Inc, Worcester, MA USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1425
引用
收藏
页码：S603 / S603
页数：1
相关论文
共 50 条
  • [1] Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry
    Kavanaugh, Arthur
    Lee, Susan J.
    Curtis, Jeffrey R.
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    Soto, Lilian
    Etzel, Carol J.
    Cox, Vanessa
    Yoshida, Kazuki
    Reed, George W.
    Solomon, Daniel H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1150 - 1155
  • [2] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
    Agarwal, Sandeep K.
    Glass, Roberta J.
    Shadick, Nancy A.
    Coblyn, Jonathan S.
    Anderson, Ronald J.
    Maher, Nancy E.
    Weinblatt, Michael E.
    Solomon, Daniel H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
  • [3] Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
    van Herwaarden, Noortje
    den Broeder, Alfons A.
    Jacobs, Wilco
    van der Maas, Aatke
    Bijlsma, Johannes W. J.
    van Vollenhoven, Ronald F.
    van den Bemt, Bart J. F.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [4] ASSOCIATION BETWEEN RHEUMATOID FACTOR STATUS AND DISCONTINUATION OF TUMOR NECROSIS FACTOR INHIBITORS DUE TO INEFFECTIVENESS IN RHEUMATOID ARTHRITIS
    Ogawa, Yoshikazu
    Takahashi, Nobunori
    Kojima, Toshihisa
    Ishiguro, Naoki
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 722 - 723
  • [5] Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis
    Roberts, L
    McColl, GJ
    [J]. INTERNAL MEDICINE JOURNAL, 2004, 34 (12) : 687 - 693
  • [6] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Dentener, Mieke A.
    Wouters, Emiel F. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2047 - 2048
  • [7] Inhibitors of tumor necrosis factor for rheumatoid arthritis
    Moreland, LW
    [J]. JOURNAL OF RHEUMATOLOGY, 1999, 26 : 7 - 15
  • [8] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Scott, D. L.
    Kingsley, G. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 704 - 712
  • [9] Tumor necrosis factor inhibitors for rheumatoid arthritis
    Jones, RE
    Moreland, LW
    [J]. BULLETIN ON THE RHEUMATIC DISEASES, 1999, 48 (03) : 1 - 4
  • [10] Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease
    Moghadam, Marjan Ghiti
    ten Klooster, Peter M.
    Vonkeman, Harald E.
    Kneepkens, Eva L.
    Klaasen, Ruth
    Stolk, Jan N.
    Tchetverikov, Ilja
    Vreugdenhil, Simone A.
    van Woerkom, Jan M.
    Goekoop-Ruiterman, Yvonne P. M.
    Landewe, Robert B. M.
    van Riel, Piet L. C. M.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    [J]. ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 516 - 524
12345